MedPath

Effect of citalopram and sertraline in treatment of depressio

Phase 4
Conditions
Depression.
Mood disorder due to known physiological condition with depressive features
F06.31
Registration Number
IRCT20171112037407N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
35
Inclusion Criteria

depression diagnosis according to diagnosis of the doctor
a total score on the HAMD more than 13 (mild to moderate depression)

Exclusion Criteria

epilepsy, liver/renal/heart diseases, other psychological disorder
had never been treated with SSRI
current treatment with other antidepressants and all of CNS drugs from 6 months ago
pregnancy and lactation
addiction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression score. Timepoint: 13 weeks later stat of treatment. Method of measurement: Hamilton Depression Rating Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath